{
  "parties": [
    "Miltenyi Biotec GmbH, a German corporation having an address at Friedrich-Ebert-Str. 68, 51429 Bergisch Gladbach, Germany (hereinafter referred to as \"Miltenyi\")",
    "Bellicum Pharmaceuticals"
  ],
  "effective_date": null,
  "governing_law": null,
  "payment_terms": {
    "text": "Payment Terms. The payment terms for all payments made by Bellicum for purchased Miltenyi Products shall be as follows:\n\n(a) Except as otherwise provided herein, all undisputed and properly due payments are payable within [...***...] days of Bellicum's receipt of each invoice corresponding to a shipment of Miltenyi Products by Miltenyi, such invoices to be issued by Miltenyi or the applicable Miltenyi Affiliate in the Forecast Territory.\n\n(b) Bellicum shall make all payments by wire transfer or electronic fund transfer in immediately available funds to an account designated by Miltenyi or its",
    "start": 125695,
    "end": 126295,
    "text_normalized": "Payment Terms. The payment terms for all payments made by Bellicum for purchased Miltenyi Products shall be as follows:\n\n(a) Except as otherwise provided herein, all undisputed and properly due payments are payable within [...***...] days of Bellicum's receipt of each invoice corresponding to a shipment of Miltenyi Products by Miltenyi, such invoices to be issued by Miltenyi or the applicable Miltenyi Affiliate in the Forecast Territory.\n\n(b) Bellicum shall make all payments by wire transfer or electronic fund transfer in immediately available funds to an account designated by Miltenyi or its"
  },
  "termination_clause": {
    "text": "termination of this Agreement.\n\n\"Clinical Grade Product\" means any Miltenyi Product designated as \"Clinical Grade\" in the attached Exhibit B, Column \"Quality Status\".\n\n\"Commercial Phase\" means, on a Bellicum Product-by-Bellicum Product basis, the period of time during the Term of this Agreement following the approval by the FDA or other applicable Regulatory Authorities in the Designated Countries for a particular Bellicum Product, during which period of time Bellicum desires Miltenyi to supply Bellicum, its Subcontractors and/or Licensees with Miltenyi Product(s).\n\n1\n\n\n\n\n\nMiltenyi Biotec-Bellicum Supply Agreement (Execution Copy, March 27, 2019)\n\n\"[...***...]\" shall mean, with respect to the efforts and resources required to fulfill any obligation hereunder, the use of [...***...] of companies in th",
    "start": 6869,
    "end": 7680
  },
  "_doc_id": "BELLICUMPHARMACEUTICALS,INC_05_07_2019-EX-10.1-Supply Agreement.txt",
  "_char_count": 188674,
  "payment_net_days": null,
  "_issues": [
    {
      "field": "effective_date",
      "type": "MISSING",
      "detail": "Required field 'effective_date' is missing"
    },
    {
      "field": "governing_law",
      "type": "MISSING",
      "detail": "Required field 'governing_law' is missing"
    }
  ]
}